Stäubli Robotics is privately owned and one of the leaders in advanced industrial automation. The company designs, manufactures, and markets a complete range of robots adapted to all needs, even the most specific, such as in the field of medicine.
Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer.
This strategic partnership aims to combine this savoir-faire to strengthen the role of robotics in minimally invasive cancer treatments and to build a world leader.
A memorandum of understanding has been signed by the two parties.
“We are extremely grateful and proud that Quantum Surgical confirms their trust in Stäubli as a partner of choice for this new patient care application, at the service of human well-being. We are excited to contributing to Quantum’s vision together, with a long-term partner that stimulates us on a daily basis and makes us better.” announces Gerald Vogt, General Manager Stäubli Robotics.
“We are honored to work with Stäubli, a company recognized for its technological excellence and savoir-faire, in order to share a vision of robotics and automation in healthcare,” explains Bertin Nahum, President, and Founder of Quantum Surgical.